NEXGEL (NXGL) CEO Adam R. Levy sells 2,000 common shares at $0.5859

Rhea-AI Filing Summary

NEXGEL, INC. Chief Executive Officer Adam R. Levy reported an open-market sale of common stock. He sold 2,000 shares of Common Stock at a price of $0.5859 per share on June 1, 2026. After this transaction, he directly owned 342,692 shares of NEXGEL common stock, so the sale represents a small portion of his overall reported holdings.

Insider Trade Summary

Net Seller: 2,000 shares ($1,172)

Net Sell 1 txn

Insider Levy Adam R.

Role Chief Executive Officer

Sold 2,000 shs ($1K)

Type	Security	Shares	Price	Value
Sale	Common Stock	2,000	$0.5859	$1K

Holdings After Transaction: Common Stock — 342,692 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares sold: 2,000 shares Sale price per share: $0.5859 per share Shares held after transaction: 342,692 shares +1 more

4 metrics

Shares sold 2,000 shares Open-market sale of NEXGEL Common Stock on June 1, 2026

Sale price per share $0.5859 per share Price received for each share sold by CEO

Shares held after transaction 342,692 shares CEO’s direct NEXGEL Common Stock ownership following the sale

Net shares sold in period 2,000 shares transactionSummary shows net-sell direction for this Form 4

Key Terms

Common Stock, open-market sale, Form 4, non-derivative

4 terms

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

open-market sale financial

"transaction_action: "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

non-derivative financial

"transaction_type: "non-derivative""

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Levy Adam R.

(Last) (First) (Middle)

C/O NEXGEL, INC.

2150 CABOT BLVD, WEST, SUITE B

(Street)

LANGHORNE PENNSYLVANIA 19047

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NEXGEL, INC. [ NXGL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/01/2026		S		2,000	D	$0.5859(1)	342,692	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Reporting Person sold all 2,000 shares of common stock in the open market at a price of $0.5859 per share.

	/s/ Adam R. Levy	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did NEXGEL (NXGL) report for Adam R. Levy?

NEXGEL reported that CEO Adam R. Levy sold 2,000 shares of Common Stock. The shares were sold in an open-market transaction at $0.5859 per share, as disclosed in the Form 4 filing.

At what price did NEXGEL (NXGL) CEO sell his shares?

Adam R. Levy sold his NEXGEL Common Stock at $0.5859 per share. The Form 4 notes this price for all 2,000 shares sold in the open market on June 1, 2026.

How many NEXGEL (NXGL) shares does the CEO hold after the sale?

After the reported sale, Adam R. Levy directly holds 342,692 shares of NEXGEL Common Stock. This figure comes from the Form 4 and reflects his ownership immediately following the 2,000-share disposition.

Was the NEXGEL (NXGL) CEO’s transaction a buy or a sell?

The transaction was a sell. The Form 4 classifies it with code “S” as an open-market sale, and the transaction data label the direction as a sale of 2,000 NEXGEL Common Stock shares.

Did the NEXGEL (NXGL) CEO’s sale involve derivative securities?

No, the reported transaction involved only non-derivative Common Stock. The Form 4 shows zero derivative transactions and an empty derivative holdings summary for this reporting period.